Iovance Biotherapeutics I...

3.34
0.15 (4.70%)
At close: Apr 24, 2025, 3:59 PM
3.38
1.09%
After-hours: Apr 24, 2025, 07:59 PM EDT

Iovance Biotherapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
-372.18M -444.04M -395.89M -342.25M -259.58M -197.56M -123.58M -92.06M -52.89M
31.64M 33.13M 21.14M 13.98M 1.14M 1.17M 956K 952K 978K
109.63M 62.63M 84.02M 69.77M 40.89M 24.28M 20.03M 11.97M 18.9M
-5.61M -1.08M -8.78M 17.58M 5.95M -2.7M 1.16M 47K 668K
3.32M -3.54M 871K 6.01M 7.57M 6.62M -1.32M 19K -74K
-2.83M -3.48M n/a n/a 1.86M -3.4M n/a n/a n/a
-122.56M -6.52M -2.89M 24.55M 2.98M 10.01M 2.67M 416K 418K
-352.98M -361.82M -292.76M -227.94M -205.13M -158.89M -101.25M -78.71M -32.67M
-11.07M -22.29M -20.43M -37.57M -46.79M -6.92M -1.2M -1.03M -1.52M
-52.57M -212.63M -276.88M -37.71M 271.06M -96.94M n/a n/a n/a
-460.77M -205.9M -245.82M -725.21M -947.66M -417.66M -426.08M n/a -110.25M
428M 285.58M 522.7M 762.91M 676.6M 514.6M 41M 59.7M 120.66M
n/a n/a 276.88M 37.71M -271.06M 96.94M -385.08M 59.7M 10.41M
-96.41M -155.24M 256.45M 132K -317.85M 90.03M -386.28M 58.68M 8.89M
n/a n/a n/a 1M n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a -312K n/a -1.25M -642K
n/a n/a n/a n/a n/a n/a n/a n/a -49.45M
-6.64M -322K 648K 35.11M 9.38M 6.13M -373.33M 5.03M 50.67M
390.66M 462.96M 190.15M 239.27M 576.42M 6.13M 424.31M 58.69M 96.9M
-59.27M -56.84M 153.85M 11.46M 53.44M -62.73M -63.22M 38.66M 73.13M
-364.05M -384.11M -313.18M -265.51M -251.93M -165.81M -102.45M -79.74M -34.19M